3 recruiting, 1 active not recruiting, 1 not yet recruiting. 4 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Recruiting 2, Active not recruiting 1, Not yet recruiting 1 |
| Phase 1 | 1 | Recruiting 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow SHR-8068 Injection: new trials by email Literature Review of SHR-8068 Injection trials Research Report on SHR-8068 Injection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Trial of SHR-8068 Combined With Adebrelimab and Apatinib in Perioperative Treatment of Resectable Hepatocellular Carcinoma SHR-8068 Injection, Adebrelimab Injection, Apatinib Mesylate Tablets - Resectable Hepatocellular Carcinoma With Intermediate or High Recurrence Risk | Phase 2 | Not yet recruiting | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | 120 | 2026-07-01 | 2026-07-02 |
| A Phase III Study of SHR-8068 in Combination With Adebrelimab and Platinum-Containing Chemotherapy Versus Durvalumab in Combination With Platinum-Containing Chemotherapy as First-line Treatment for Advanced Biliary Tract Cancer (BTC) SHR-8068 Injection, Adebrelimab Injection, Gemcitabine Hydrochloride for Injection - Advanced Biliary Tract Cancer | Phase 3 | Recruiting | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | 604 | 2026-01-21 | 2026-01-28 |
| A Trial of Adebrelimab Plus (SHR-A1811/SHR-A1904 With Chemotherapy) or SHR-8068 as Treatment for Gastric/GEJ Cancer Adebrelimab Injection, SHR-A1811 for Injection, SHR-A1904 for Injection - Gastric Cancer, Gastroesophageal-junction Cancer | Phase 2 | Recruiting | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | 200 | 2025-08-28 | 2026-01-09 |
| A Phase II Study of SHR-8068 Injection in Combination With Anti-tumor Therapies in Colorectal Cancer SHR-8068 Injection, Adebrelimab Injection, Bevacizumab Injection - Colorectal Cancer | Phase 2 | Active not recruiting | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | 103 | 2025-07-22 | 2026-08-11 |
| A Trial of SHR-A2102 With Antitumor Therapy in Advanced Urothelial Carcinoma SHR-A2102, Adebrelimab injection, SHR-8068 injection - Advanced Urothelial Carcinoma | Phase 1 / Phase 2 | Recruiting | Shanghai Hengrui Pharmaceutical Co., Ltd. | 90 | 2024-11-04 | 2024-11-18 |
Colorectal Neoplasms (1) · Stomach Neoplasms (1)
Suzhou Suncadia Biopharmaceuticals Co., Ltd. (4) · Shanghai Hengrui Pharmaceutical Co., Ltd. (1)
China (5)